No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Biomarkers / blood
-
Bone Density Conservation Agents / adverse effects*
-
Bone Density Conservation Agents / therapeutic use
-
Denosumab
-
Female
-
Humans
-
Neoplasms / chemically induced*
-
Neoplasms / mortality
-
Osteoporosis, Postmenopausal / drug therapy*
-
Osteoprotegerin / blood
-
RANK Ligand / adverse effects*
-
RANK Ligand / antagonists & inhibitors*
-
RANK Ligand / blood
-
RANK Ligand / therapeutic use
-
Spinal Fractures / prevention & control
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Biomarkers
-
Bone Density Conservation Agents
-
Osteoprotegerin
-
RANK Ligand
-
TNFSF11 protein, human
-
Denosumab